Frontlight ResearchEarly access
Familial hypercholesterolaemia trials in Canada
4 of 5 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Where
- Chicoutimi, Montreal, Toronto
- Age
- 18 years to 70 years
- People
- 132 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06451770 · EU 2025-522617-39-00 - Phase 3Active, not recruitingLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Québec
- Age
- 2 years to 100 years
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - Phase 1Taking peopleA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Where
- Chicoutimi, Hamilton, Montreal, Québec, Toronto, Vancouver
- Age
- 18 years to 70 years
- People
- 85 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06164730 - No phaseTaking peopleTargeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
- Where
- Montreal
- Age
- 45 years to 74 years
- People
- 48
- Run by
- Institut de Recherches Cliniques de Montreal
See details and how to joinNCT04485871